Form D/A — BioLattice Ophthalmics, Inc,
0002125596-26-000003 · filed Oct 28, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $3,310,000
- Reported amount sold
- $1,825,000
- Minimum investment
- $0
- Investors
- 7
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- BioLattice Ophthalmics, Inc,
- CIK
- 2125596
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 2929 Arch Street
Philadelphia, PA 19104 - Phone
- 267 481 5423
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Linda Alunkal · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Amelia Zellander · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Gregory Jackson · DirectorPhiladelphia, PA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗